CA2307614A1 - Echinacee de qualite pharmaceutique - Google Patents

Echinacee de qualite pharmaceutique Download PDF

Info

Publication number
CA2307614A1
CA2307614A1 CA002307614A CA2307614A CA2307614A1 CA 2307614 A1 CA2307614 A1 CA 2307614A1 CA 002307614 A CA002307614 A CA 002307614A CA 2307614 A CA2307614 A CA 2307614A CA 2307614 A1 CA2307614 A1 CA 2307614A1
Authority
CA
Canada
Prior art keywords
echinacea
bioactivity
pharmaceutical grade
fingerprint
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002307614A
Other languages
English (en)
Inventor
Elliot P. Friedman
Tasneem A. Khwaja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmaPrint Inc
University of Southern California USC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2307614A1 publication Critical patent/CA2307614A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention a trait de manière générale à des matières d'échinacée et à des procédés de transformation de ces matières en formes utiles d'un point de vue médicinal et pharmaceutiquement acceptables. Plus particulièrement, l'invention a trait à l'utilisation d'empreintes de composition et d'activité dans le traitement de matières d'échinacée pour produire des médicaments qui remplissent les conditions requises pour constituer des compositions de qualité pharmaceutique convenant pour un usage clinique ou vétérinaire en vue de traiter et/ou soulager des maladies, des affections ou des états pathologiques.
CA002307614A 1997-10-23 1998-10-23 Echinacee de qualite pharmaceutique Abandoned CA2307614A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95660397A 1997-10-23 1997-10-23
US08/956,603 1997-10-23
PCT/US1998/022507 WO1999021007A1 (fr) 1997-10-23 1998-10-23 Echinacee de qualite pharmaceutique

Publications (1)

Publication Number Publication Date
CA2307614A1 true CA2307614A1 (fr) 1999-04-29

Family

ID=25498433

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002307614A Abandoned CA2307614A1 (fr) 1997-10-23 1998-10-23 Echinacee de qualite pharmaceutique

Country Status (4)

Country Link
EP (1) EP1025441A1 (fr)
AU (1) AU1363499A (fr)
CA (1) CA2307614A1 (fr)
WO (1) WO1999021007A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010003238A1 (fr) * 2008-07-11 2010-01-14 National Research Council Of Canada Alcamides induisant des protéines de phase 2
EP4161473A4 (fr) * 2020-06-05 2024-01-24 Henkel AG & Co. KGaA Utilisation d'un composé contenant deux ou plusieurs groupes hydroxyle alcooliques ou groupes hydroxyle phénoliques en tant que régulateur du microbiome sur le cuir chevelu

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1220680T3 (da) * 1999-09-30 2008-07-14 Factors R & D Technologies Ltd Echinacea-tilskud og fremgangsmåde til fremstilling
JP4709459B2 (ja) * 2000-03-06 2011-06-22 ユニリーバー・ナームローゼ・ベンノートシヤープ 美容組成物中の抗刺激および抗老化増強物質としてのエキナセア抽出物
US6991811B1 (en) 2000-05-19 2006-01-31 Access Business Group International Llc Echinacea induction of phase II enzymes
US6306443B1 (en) 2000-06-20 2001-10-23 Amway Corporation Method of increasing concentrations of caffeic acid derivatives and alkylamides and compositions containing the same
EP1424101A3 (fr) * 2002-11-29 2004-08-18 NOZAKI, Masako Utilisation d'un antagoniste du leucotriène c4/d4 pour la préparation d'un médicament pour le traitement ou la prévention d'une inflammation ou septicémie du cerveau
US7148248B2 (en) 2002-11-29 2006-12-12 Masako Nozaki Method of treating or inhibiting the development of brain inflammation and sepsis
CN101022796B (zh) 2004-07-14 2013-02-27 炎症研究中心有限公司 抑制肿瘤转移的方法
US7491414B2 (en) 2005-10-12 2009-02-17 Gaia Herbs, Inc. Anti-inflammatory substances extracted from Echinacea
CH699653B1 (de) * 2008-09-08 2010-05-14 Bioforce Ag Roggwil Tg Zubereitung zur Prävention und/oder Behandlung und/oder Verhinderung der Weiterverbreitung von Atemwegserkrankungen.
ITMI20090049A1 (it) 2009-01-20 2010-07-21 Indena Spa Composizioni a base di estratti lipofili di zingiber officinale e di echinacea angustifolia per la prevenzione e il trattamento del riflusso gastro-esofageo e dell'emesi indotta da chemioterapici
IT1401141B1 (it) * 2010-07-26 2013-07-12 Indena Spa Formulazioni contenenti estratti di echinacea angustifolia e di zingiber officinale utili nella riduzione dell'infiammazione e del dolore periferico
EP2647722B1 (fr) * 2010-12-03 2016-07-06 Tsumura & Co. Méthode de biodosage de daikenchuto et procédé de gestion de qualité à l'aide de celle-ci
CN104127463B (zh) * 2014-07-01 2018-08-28 青岛蔚蓝生物股份有限公司 一种紫锥菊提取物及其制备方法和应用
CN112415104B (zh) * 2020-10-26 2022-04-12 四川新绿色药业科技发展有限公司 一种有柄石韦药材及其饮片、标准汤剂、配方颗粒的特征图谱、构建方法和检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0464298T3 (da) * 1990-07-05 1995-11-13 Indena Spa Echinacea-ekstrakter, fremgangsmåde til fremstilling deraf og formuleringer, der indeholder dem
US6379714B1 (en) * 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
EP0824355A4 (fr) * 1995-04-14 1998-12-30 Univ Southern California Extrait de gui et compose correspondant

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010003238A1 (fr) * 2008-07-11 2010-01-14 National Research Council Of Canada Alcamides induisant des protéines de phase 2
EP4161473A4 (fr) * 2020-06-05 2024-01-24 Henkel AG & Co. KGaA Utilisation d'un composé contenant deux ou plusieurs groupes hydroxyle alcooliques ou groupes hydroxyle phénoliques en tant que régulateur du microbiome sur le cuir chevelu

Also Published As

Publication number Publication date
WO1999021007A9 (fr) 1999-07-08
EP1025441A1 (fr) 2000-08-09
AU1363499A (en) 1999-05-10
WO1999021007A1 (fr) 1999-04-29

Similar Documents

Publication Publication Date Title
WO1999021009A9 (fr) Chou palmiste nain de qualite pharmaceutique, serenoa repens
US6113907A (en) Pharmaceutical grade St. John's Wort
CA2307614A1 (fr) Echinacee de qualite pharmaceutique
Akhtar et al. Appraisal of anti-arthritic and anti-inflammatory potential of folkloric medicinal plant Peganum harmala
CN1239547A (zh) 药物等级植物药
Liu et al. A Chinese medicine formula (Jinqi Jiangtang Tablet): a review on its chemical constituents, quality control, pharmacokinetics studies, pharmacological properties and clinical applications
Huang et al. Quality evaluation for Radix Astragali based on fingerprint, indicative components selection and QAMS
Xie et al. Recent advances and effective strategies in the discovery and applications of natural products
Hasan et al. Inhibitory effects of Clematis orientalis aqueous ethanol extract and fractions on inflammatory markers in complete Freund's adjuvant-induced arthritis in Sprague–Dawley rats: UH Hassan et al.
Gupta et al. Development of a spectrofluorimetric method for the determination of curcumin
WO1999021008A1 (fr) Ail de qualite pharmaceutique
Malematja et al. Potential hypoglycaemic and antiobesity effects of Senna italica leaf acetone extract
AU1363399A (en) Pharmaceutical grade ginkgo biloba
WO1999020292A1 (fr) Ginseng de qualite pharmaceutique
Rajput et al. Scientific evaluation of Panchkola churna–an Ayurvedic polyherbal drug formulation
CN110638990B (zh) 一种桂枝芍药知母处方制剂提取物的提取工艺
WO1999021006A9 (fr) Valeriane, actee a grappes, vitex agnus-castus, airelle et chardon-marie de qualite pharmaceutique
Gupta et al. CYTOTOXIC AND ANTI-INFLAMMATORY ACTIVITY OF AQUEOUS EXTRACT OF Strychnos nux-vomica
AU1363199A (en) Pharmaceutical grade st. john's wort
Olusegun et al. Hepatoprotective potential of Russelia equisetiformis plant extract on drug-induced hepatotoxicity in experimental models
CN120609956B (zh) 一种采用薄层色谱法检测跌打镇痛膏中3种药材的方法
Apitikori-owumi et al. The Growth Inhibitory study of Methanol Extract and Fractions of Seeds of Chrysobalanus icaco (Chrysobalanceae)
CN107894466A (zh) 一种金桑芪抗毒制剂hplc指纹图谱的测定方法及金桑芪抗毒制剂质量控制方法
Rininger et al. In vitro immunopharmacology of Echinacea
Anokwuru Phytochemical, biological and toxicity studies of Terminalia sericea Burch.(Combretaceae)

Legal Events

Date Code Title Description
FZDE Discontinued